Cargando…

Program of algorithm for pharmacological treatment of major depressive disorder in China: Benefits or not?

BACKGROUND: This research was designed to investigate Algorithm Guided Treatment (AGT) and clinical traits for the prediction of antidepressant treatment outcomes in Chinese patients with major depressive disorder (MDD). METHODS: This study included 581 patients who had reached treatment response an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yuncheng, Wang, Fang, Wang, Fan, Liu, Hongmei, Guo, Xiaoyun, Wang, Zuowei, He, Ruoqiao, Wu, Xiaohui, Cao, Lan, Wu, Zhiguo, Peng, Daihui, Fang, Yiru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618797/ https://www.ncbi.nlm.nih.gov/pubmed/37920522 http://dx.doi.org/10.1016/j.heliyon.2023.e20951

Ejemplares similares

Clinical Guideline (CANMAT 2016) Discordance of Medications for Patients with Major Depressive Disorder in China
por: Zhu, Yuncheng, et al.
Publicado: (2023)

Identifying the Subtypes of Major Depressive Disorder Based on Somatic Symptoms: A Longitudinal Study Using Latent Profile Analysis
por: Wu, Xiaohui, et al.
Publicado: (2022)

Biochemical and Endocrine Parameters for the Discrimination and Calibration of Bipolar Disorder or Major Depressive Disorder
por: Zhu, Yuncheng, et al.
Publicado: (2022)

Association between olfactory function and inhibition of emotional competing distractors in major depressive disorder
por: Wang, Fang, et al.
Publicado: (2020)

Abnormal white matter integrity in Chinese young adults with first-episode medication-free anxious depression: a possible neurological biomarker of subtype major depressive disorder
por: Xia, Weiping, et al.
Publicado: (2018)

Identification of IL6 as a susceptibility gene for major depressive disorder
por: Zhang, Chen, et al.
Publicado: (2016)

Evaluation of antidepressant polypharmacy and other interventions for treatment-resistant depression
por: PENG, Daihui, et al.
Publicado: (2014)

Gene expression signatures differentiating major depressive disorder from subsyndromal symptomatic depression
por: Hu, Guoqin, et al.
Publicado: (2021)

Effects of tumor necrosis factor-α polymorphism on the brain structural changes of the patients with major depressive disorder
por: Zhou, Rubai, et al.
Publicado: (2018)

Blood-Based Gene Expression Profiles Models for Classification of Subsyndromal Symptomatic Depression and Major Depressive Disorder
por: Yi, Zhenghui, et al.
Publicado: (2012)

Guidelines Disconcordance in Acute Bipolar Depression: Data from the National Bipolar Mania Pathway Survey (BIPAS) in Mainland China
por: Wang, Zuowei, et al.
Publicado: (2014)

Probing the clinical and brain structural boundaries of bipolar and major depressive disorder
por: Yang, Tao, et al.
Publicado: (2021)

Differential gene expression in patients with subsyndromal symptomatic depression and major depressive disorder
por: Yang, Chengqing, et al.
Publicado: (2017)

P300 event-related potentials in patients with different subtypes of depressive disorders
por: Wang, Yun, et al.
Publicado: (2023)

Surface Vulnerability of Cerebral Cortex to Major Depressive Disorder
por: Peng, Daihui, et al.
Publicado: (2015)

Correction: Surface Vulnerability of Cerebral Cortex to Major Depressive Disorder
por: Peng, Daihui, et al.
Publicado: (2015)

Comorbidity of depressive and anxiety disorders: challenges in diagnosis and assessment
por: WU, Zhiguo, et al.
Publicado: (2014)

Are subsyndromal symptomatic depression and major depressive disorder distinct disorders?
por: Yi, Zhenghui, et al.
Publicado: (2012)

Pharmacotherapy for acute mania and disconcordance with treatment guidelines: bipolar mania pathway survey (BIPAS) in mainland China
por: Wang, Zuowei, et al.
Publicado: (2014)

TNF-α, IL-6 and hsCRP in patients with melancholic, atypical and anxious depression: an antibody array analysis related to somatic symptoms
por: Liu, Hongmei, et al.
Publicado: (2022)

Lower Health Literacy of Mania Than Depression Among Older People: A Random Survey of a Community Healthcare Service Center
por: Huang, Leping, et al.
Publicado: (2021)

The Developmental and Translational Study on Biomarkers and Clinical Characteristics-based Diagnostic and Therapeutic Identification of Major Depressive Disorder: Study Protocol for a Multicenter Randomized Controlled Trial in China
por: Liu, Xiaohua, et al.
Publicado: (2020)

A Preliminary Study of Different Treatment Strategies for Anxious Depression
por: Wang, Yun, et al.
Publicado: (2022)

Concordance of the treatment patterns for major depressive disorders between the Canadian Network for Mood and Anxiety Treatments (CANMAT) algorithm and real-world practice in China
por: Yang, Lu, et al.
Publicado: (2022)

A Preliminary Randomized Controlled Trial of Different Treatment Regimens for Melancholic Depression
por: Wang, Yun, et al.
Publicado: (2021)

Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications
por: Li, Zezhi, et al.
Publicado: (2021)

Association between brain-derived neurotrophic factor genetic polymorphism Val66Met and susceptibility to bipolar disorder: a meta-analysis
por: Wang, Zuowei, et al.
Publicado: (2014)

Variants in the Upstream Region of the Insulin Receptor Substrate-1 Gene Is Associated with Major Depressive Disorder in the Han Chinese Population
por: Wang, Fan, et al.
Publicado: (2020)

PAID study design on the role of PKC activation in immune/inflammation-related depression: a randomised placebo-controlled trial protocol
por: Guo, Xiaoyun, et al.
Publicado: (2021)

COVID‐19 and post‐traumatic stress disorder: A vicious circle involving immunosuppression
por: Liang, Xiao, et al.
Publicado: (2020)

Response Inhibition and Emotional Regulation in the Patients with Attention-Deficit/Hyperactivity Disorder and Comorbidity of Disruptive, Impulse-Control, and Conduct Disorders
por: Jiang, Xixi, et al.
Publicado: (2019)

The Metabolic Factor Kynurenic Acid of Kynurenine Pathway Predicts Major Depressive Disorder
por: Liu, Hongye, et al.
Publicado: (2018)

Potential mechanisms of non-suicidal self-injury (NSSI) in major depressive disorder: a systematic review
por: Wu, Baichuan, et al.
Publicado: (2023)

Comorbidity and Treatment in Older Psychiatric In-patients—A Retrospective Study in a Chinese Psychiatric Hospital
por: Liu, Hongmei, et al.
Publicado: (2021)

Pharmacological Treatment of Major Depressive Disorder in Adolescents
por: Farley, Rachel L.
Publicado: (2005)

Functional Status of Hypothalamic–Pituitary–Thyroid and Hypothalamic–Pituitary–Adrenal Axes in Hospitalized Schizophrenics in Shanghai
por: Zhu, Yuncheng, et al.
Publicado: (2020)

Lack of Association Between PLA2G6 Genetic Variation and Parkinson’s Disease: A Systematic Review
por: Liu, Hongmei, et al.
Publicado: (2020)

Susceptibility of schizophrenia and affective disorder not associated with loci on chromosome 6q in Han Chinese population
por: Wang, Zuowei, et al.
Publicado: (2007)

Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews
por: Gartlehner, Gerald, et al.
Publicado: (2017)

Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China
por: Wang, Gang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vmdqsu608f70j18m4ai019oeuh